AURP BIO Health Caucus: June 12-13, 2022
Designing, Building & Finding Research Space for Growing Bio Companies & Bio Clusters ...
Fzata Winner of Mid-Atlantic Innovation Celebration, Biotechnology
Fzata, Inc., a biotech innovator, is proud to announce that it has been named the winner of the 2022 Mid-Atlantic Innovation Celebration for Biotechnology for its oral Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. The Company is honored to have been selected for this award from among so many highly innovative competitors. ...
Creatv Bio’s LifeTracDx® Liquid Biopsy Predicts Response to New Line of Therapy for Metastatic Breast Cancer within 30 Days
Creatv Bio’s LifeTracDx® Liquid Biopsy Predicts Response to New Line of Therapy for Metastatic Breast Cancer within 30 Days ...
Johns Hopkins University Summer STEM Programs
It’s time for FCPS high school juniors and seniors to apply for the Johns Hopkins University (JHU) Explore Engineering Innovation (EEI) and Biomedical Engineering Innovation (BMEI) summer programs, offered at Hood College. ...
MIMETAS expanded its license to the HUB Organoid Technology to include all organs – Drug Discovery & Development
MIMETAS, a global leader in Organ-on-a-Chip models and technology and headquartered in the Netherlands (Europe), announces that it has expanded its license to the HUB Organoid Technology to include all organs. The license covers organoid technology developed by Professor Hans Clevers, a pioneer in adult stem cells. ...
Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages
GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into a definitive agreement with Chimerix, Inc. (NASDAQ: CMRX), to acquire Chimerix’s exclusive worldwide rights to TEMBEXA® (brincidofovir), the first antiviral approved by the U.S. Food and Drug Administration (FDA) for all age groups for the treatment of smallpox. TEMBEXA was approved in June 2021 and is indicated for the treatment of human smallpox disease in adult and pediatric patients, including neonates. ...
The National Institutes of Health, a Technology Transfer Wellspring
The National Institutes of Health (NIH) is a critical pillar of the U.S. public health system and a beacon of guidance for healthcare best practices across the globe. This has never been more evident than during the COVID-19 crisis. ...
$20 M Raised to Fight Superbugs
Adaptive Phage Therapeutics (APT) received $20 M in Series B funding. APT has now raised a total of $61 M in Series B funding, accelerating clinical trials for prosthetic joint infection and diabetic foot osteomyelitis. ...
These 8 Equity-focused Companies are Set to Take Baltimore to the Moon
Investment management giant T. Rowe Price and nonprofit Baltimore Corps recently partnered on a new initiative that aims to get more Black founders and other entrepreneurs of color in the room with angel investors and funders. ...
Global expansion opportunities for Maryland businesses
Interested in growing your business in the global market? ...